Showing results (91-100 of 967) with videos related to
Sort By:
Pageof 97
Dermatology and Therapy|July 15, 2018
Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United StatesSteven R Feldman, Shipra Rastogi, Jay LinJournal of Drugs in Dermatology : JDD|June 16, 2006
Clobetasol propionate for psoriasis: are ointments really more potent?Lindsey Warino, Rajesh Balkrishnan, Steven R FeldmanSouthern Medical Journal|January 5, 2017
Advances in PsoriasisJaclyn Smith, Abigail Cline, Steven R FeldmanJMIR Dermatology|August 26, 2023
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative AnalysisRohan Singh, Sarah McCain, Steven R FeldmanThe Annals of Pharmacotherapy|June 21, 2023
Choosing Systemic Agents for PsoriasisChristina Kontzias, Rithi Chandy, Steven R FeldmanThe Journal of Dermatological Treatment|July 7, 2009
Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectationsElizabeth E Uhlenhake, David Kurkowski, Steven R FeldmanDermatology Online Journal|March 9, 2011
Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study populationPaul Persad, Michelle M Levender, Steven R FeldmanJournal of the American Academy of Dermatology|December 18, 2016
Relative versus absolute risk of comorbidities in patients with psoriasisMohammed D Saleem, Chelsea Kesty, Steven R FeldmanThe Journal of Dermatological Treatment|January 24, 2006
The role of commercial tanning beds and ultraviolet A light in the treatment of psoriasisJohanna Su, Daniel J Pearce, Steven R FeldmanPageof 97